Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lukács Kiss, Dániel KálmánfiledCriticalLukács Kiss
Priority to HU9802379ApriorityCriticalpatent/HU220182B/en
Publication of HU9802379D0publicationCriticalpatent/HU9802379D0/en
Publication of HUP9802379A1publicationCriticalpatent/HUP9802379A1/en
Publication of HU220182BpublicationCriticalpatent/HU220182B/en
An inhaler contains 40-250 g crystalline iodine containing mineral salt of volcanic origin. 35-60% Of this salt is of 1-1.5 mm grain size and 40-65% of 5-6 mm particle size. The salt mixture is placed in a cylindrical (preferred) or a rectangular container, complete with a suitable outlet and on the opposite side with one or more inlets of a greater area than the outlet.
HU9802379A1998-10-151998-10-15Inhaler for treatment of asthma
HU220182B
(en)
Method for providing stable crystalline form of micronized substance in non-agglomerated form and composition containing micronized ipratropiumbromide or dihydrate of fumarate formoterol
Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
A metered dose inhaler comprising a canister containing an aerosol formulation comprising levalbuterol l-tartrate, and use of levalbuterol l-tartrate in the manufacture of said metered dose inhaler for treating bronchospasm.
New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml comprising terbutaline sulphate a process for preparing the formulation and the use thereof